Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ben C. Valdez

Myeloablative Timed Sequential Busulfan Is Safe in Patients With Relapsed or High-Risk Multiple Myeloma

Biology of Blood and Marrow Transplantation

Transplantation

English

Related publications

Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma

European Journal of Medical Research

English

CD34-selected Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Relapsed, High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia

Cancer Research

English

Carfilzomib for Relapsed or Refractory Multiple Myeloma

The Lancet Oncology

English

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia

Clinical Hematology International

English

Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation in Vivo in High-Risk Relapsed Multiple Myeloma Patients

Journal of immunotherapy (Hagerstown, Md. : 1997)

Cancer Research

English

Carfilzomib Monotherapy in Japanese Patients With Relapsed or Refractory Multiple Myeloma: A Phase 1/2 Study

Cancer Research

English

Methodology of a Novel Risk Stratification Algorithm for Patients With Multiple Myeloma in the Relapsed Setting

Oncology and Therapy

English

FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia

Cancer Research

English

Efficacy of Subcutaneous Bortezomib in the Management of Patients With Multiple Myeloma or Relapsed Mantle Cell Lymphoma

Clinical Medicine Insights: Therapeutics

Pharmaceutical Science

English